The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022.

Authors :: Ducreux M
Abou-Alfa GK
Bekaii-Saab T
Berlin J
Cervantes A
de Baere T
Eng C
Galle P
Gill S
Gruenberger T
Haustermans K
Lamarca A
Laurent-Puig P
Llovet JM
Lordick F
Macarulla T
Mukherji D
Muro K
Obermannova R
O'Connor JM
O'Reilly EM
Osterlund P
Philip P
Prager G
Ruiz-Garcia E
Sangro B
Seufferlein T
Tabernero J
Verslype C
Wasan H
Van Cutsem E
Source :: ESMO open [ESMO Open] 2023 Jun; Vol. 8 (3), pp. 101567. Date of Electronic Publication: 2023 May 31.
Publication Year :: 2023
Abstract: This article summarises expert discussion on the management of patients with hepatocellular carcinoma (HCC), which took place during the 24th World Gastrointestinal Cancer Congress (WGICC) in Barcelona, July 2022. A multidisciplinary approach is mandatory to ensure an optimal diagnosis and staging of HCC, planning of curative and therapeutic options, including surgical, embolisation, ablative strategies, or systemic therapy. Furthermore, in many patients with HCC, underlying liver cirrhosis represents a challenge and influences the therapeutic options.<br /> (Copyright © 2023 The Author(s). Published by Elsevier Ltd.. All rights reserved.)

Subjects :: Humans
Practice Guidelines as Topic
Carcinoma, Hepatocellular diagnosis
Carcinoma, Hepatocellular therapy
Gastrointestinal Neoplasms diagnosis
Gastrointestinal Neoplasms therapy
Liver Neoplasms diagnosis
Liver Neoplasms therapy

Full Text Access

Tools